Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

2,3,4,5 tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole dihydrochloride

EU orphan designation number: EU/3/08/597   
Active ingredient: 2,3,4,5 tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole dihydrochloride
Indication: Treatment of Huntington's disease
Sponsor: IDEA Innovative Drug European Associates Limited
4th Floor, 1 Kingdom Street, Paddington, London W2 6BD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/01/2009 Centralised Orphan - Designation EMEA/OD/061/08 (2009)424 of 20/01/2009
01/03/2011 Other procedure EMEA/OD/061/08
17/12/2012 Other procedure
25/09/2014 Centralised Orphan - Change of address